DKSH will be the only distributor for all Postnova Field-Flow Fractionation products http://www.postnova.com/ .For Malaysian market, it will contribute earnings to DKSH Malaysia.
complicated products ??? wat so complicated about regular household products? in my opinion if dksh is so good... why cant they operate well in their own territory since its a swiss company? there must be something going on for this company... not so easy...
in my opinion dksh is just a distributor and there are many other ways to distribute goods. So to me fair value = book value = RM2.95 (according to bloomberg)
good stock no need big timer support... eventually the price will reflect its true value.. double digit grower... excellent service provider(efficient and accurate supplier), foreign owned, all hypermarkets, supermarkets, pharmacies etc depend on DKSH.
entered at 6.57. exit at 6.71. regardless of the free fall, this kind of counter shall never be the same like those penny stocks. it is not reversing but at least, the bleeding has stopped. give another day to confirm the trend.
DKSH extends partnership with Novo Nordisk in Malaysia 01.10.2014 | DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement to provide commercial and distribution services to Novo Nordisk, a global healthcare company with 90 years of experience in diabetes care, in Malaysia.
Kuala Lumpur, Malaysia, October 1, 2014 – DKSH Business Unit Healthcare, the leading partner for healthcare companies seeking to grow their business in Asia, has signed an agreement to provide marketing, sales and distribution services for Novo Nordisk’s NovoFine® insulin needles in pharmacy channels in Malaysia.
“DKSH’s commitment to quality and compliance as well as track record in the healthcare industry has made them our partner of choice. We are confident that this partnership will help strengthen NovoFine® insulin needles position in the pharmacy channels and give patients better access to our diabetic care products,” said Noha Shawky, General Manager, Novo Nordisk Pharma, Malaysia.
“We are pleased that Novo Nordisk has chosen DKSH to support NovoFine® insulin needles with our extensive commercial capabilities. The agreement reflects our strength, reputation and unrivalled capillary distribution network in the healthcare channels in Malaysia,” commented Dr. Marc Franck, Vice President Business Unit Healthcare, DKSH Malaysia.
DKSH already provides an integrated Market Expansion Services service portfolio that includes marketing and sales, distribution and logistics, credit management and collection services for Novo Nordisk’s entire product range to the hospital, clinic and pharmacy channels in Malaysia.
The new partnership will further strengthen DKSH’s market position in Malaysia while contributing incrementally to the Group’s overall profitability over time.
About Novo Nordisk Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.
thank you reachabble for sharing. bought some at rm7+. need to average on earlier purchase.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
Report Abuse
Please Sign In to report this post as abuse.
Market Buzz
No result.
Featured Posts
MQ Trader
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
mcloh
18 posts
Posted by mcloh > 2014-08-06 17:19 | Report Abuse
if bear come, then it will